Literature DB >> 2156815

Human platelets form 3-phosphorylated phosphoinositides in response to alpha-thrombin, U46619, or GTP gamma S.

G L Kucera1, S E Rittenhouse.   

Abstract

Human platelets stimulated with alpha-thrombin or the thromboxane A2 analogue U46619 form the novel phosphatidylinositol (PtdIns) polyphosphate species PtdIns (3,4)P2 and PtdIns(3,4,5)P3 in a time- and dose-dependent manner. In [32P]o-phosphate-labeled platelets, PtdIns(3,4)P2 increases in 2 min to 613% of the basal level in response to 1 unit/ml alpha-thrombin and 295% in response to 5 microM U46619. A dramatic increase is also observed with myo-[3H]inositol-labeled platelets. [32P]PtdIns(3,4,5)P3 is increased with alpha-thrombin and U46619 stimulation by 261 and 183%, respectively. PtdIns(3)P quantities remain nearly equal to those under resting conditions. Neither the basal nor increased levels of PtdIns(3,4)P2 appear to be adequate to account for the rapid elevation of Ins(1,3,4)P3 that we have observed in alpha-thrombin-stimulated platelets. A23187 and/or phorbol 12,13-dibutyrate are not as potent as alpha-thrombin in stimulating changes in PtdIns(3,4)P2 or PtdIns(3,4,5)P3. GTP gamma S (10 microM), however, increases the level of PtdIns(3,4)P2 by 3736% and that of PtdIns(3,4,5)P3 by 456% in saponin-permeabilized platelets incubated with 0.5 mM [gamma-32P]ATP, implying a role for a GTP-binding protein in promoting phosphatidylinositide 3-kinase activity(ies). This is the first report of stimulated generation of 3-phosphorylated phosphoinositides in anucleate cells. A role for these novel phospholipid species in signal transduction, however, awaits elucidation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2156815

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

1.  Accumulation of PtdIns(3,4)P2 and PtdIns(3,4,5)P3 in thrombin-stimulated platelets. Different sensitivities to Ca2+ or functional integrin.

Authors:  A Sorisky; W G King; S E Rittenhouse
Journal:  Biochem J       Date:  1992-09-01       Impact factor: 3.857

2.  Akt signaling in platelets and thrombosis.

Authors:  Donna S Woulfe
Journal:  Expert Rev Hematol       Date:  2010-02       Impact factor: 2.929

3.  Relationship between phosphoinositide kinase activities and protein tyrosine phosphorylation in plasma membranes from A431 cells.

Authors:  B Payrastre; M Plantavid; M Breton; E Chambaz; H Chap
Journal:  Biochem J       Date:  1990-12-15       Impact factor: 3.857

4.  Ras activation in platelets after stimulation of the thrombin receptor, thromboxane A2 receptor or protein kinase C.

Authors:  D D Shock; K He; J D Wencel-Drake; L V Parise
Journal:  Biochem J       Date:  1997-01-15       Impact factor: 3.857

5.  BW755C or staurosporine inhibits collagen-stimulated phosphoinositide phosphorylation in platelets.

Authors:  L M Thomas; B J Holub
Journal:  Lipids       Date:  1991-09       Impact factor: 1.880

6.  Mas oncogene signaling and transformation require the small GTP-binding protein Rac.

Authors:  I E Zohn; M Symons; M Chrzanowska-Wodnicka; J K Westwick; C J Der
Journal:  Mol Cell Biol       Date:  1998-03       Impact factor: 4.272

Review 7.  Membrane-trafficking sorting hubs: cooperation between PI4P and small GTPases at the trans-Golgi network.

Authors:  Felipe H Santiago-Tirado; Anthony Bretscher
Journal:  Trends Cell Biol       Date:  2011-07-19       Impact factor: 20.808

8.  G proteins of the G12 family are activated via thromboxane A2 and thrombin receptors in human platelets.

Authors:  S Offermanns; K L Laugwitz; K Spicher; G Schultz
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

9.  Dynamics of capping protein and actin assembly in vitro: uncapping barbed ends by polyphosphoinositides.

Authors:  D A Schafer; P B Jennings; J A Cooper
Journal:  J Cell Biol       Date:  1996-10       Impact factor: 10.539

10.  Disruption of GLUT1 glucose carrier trafficking in L6E9 and Sol8 myoblasts by the phosphatidylinositol 3-kinase inhibitor wortmannin.

Authors:  P Kaliman; F Viñals; X Testar; M Palacín; A Zorzano
Journal:  Biochem J       Date:  1995-12-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.